Alok A. Khorana, M.D., F.A.C.P, F.A.S.C.O, is Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, the Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services of the Taussig Cancer Institute (part of Case Comprehensive Cancer Center) and Director of the Gastrointestinal Malignancies Program at the Cleveland Clinic, Cleveland, Ohio. His clinical and translational research program focuses on predictive factors and drug development in cancer-associated thrombosis and gastrointestinal cancers and has been funded by grants from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the Hardis Family, the Porter Family Fund, VeloSano, the Cleveland Clinic Center for Excellence, the Scott Hamilton CARES Initiative, Stand Up To Cancer (Colorectal Cancer “Dream Team”) and the V Foundation.
Dr. Khorana received his medical degree from Maharaja Sayajirao University’s Medical College in Baroda (now Vadodara, Gujarat), India. His postdoctoral training included a residency in internal medicine at the University at Buffalo in New York and a fellowship in hematology/oncology at the University of Rochester, New York. He is a Fellow of the American College of Physicians and in 2018 was elected Fellow of the American Society of Clinical Oncology.
Dr. Khorana is Past Chair of the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines Panel (CPGC), Chair of ASCO CPGC’s Pancreas Cancer Working Group, Co-Chair of ASCO CPGC’s Multisite Advisory Group and Co-Chair of the ASCO Guidelines Panel on Resectable Pancreas Cancer. He is currently Chair of the Medical and Scientific Advisory Board of the National Blood Clot Association. He has also served or serves on the ASCO Scientific Program Committee and multiple Guidelines/Guidance Panels.
Goyal, L., Sirard, C., Schrag, M., Kagey, M. H., Eads, J. R., Stein, S., El-Khoueiry, A. B., Manji, G. A., Abrams, T. A., Khorana, A. A., Miksad, R., Mahalingam, D., Z...> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Sep 4
Farge, D., Frere, C., Connors, J. M., Ay, C., Khorana, A. A., Munoz, A., Brenner, B., Kakkar, A., Rafii, H., Solymoss, S., Brilhante, D., Monreal, M., Bounameaux, H., ...> ;The Lancet. Oncology. 2019 Sep 8
Key, N. S., Khorana, A. A., Kuderer, N. M., Bohlke, K., Lee, A. Y., Arcelus, J. I., Wong, S. L., Balaban, E. P., Flowers, C. R., Francis, C. W., Gates, L. E., Kakkar, ...> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Aug 6
Khorana, A. A., McKernin, S. E., Berlin, J., Hong, T. S., Maitra, A., Moravek, C., Mumber, M., Schulick, R., Zeh, H. J., Katz, M. H.> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Jun 11
Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis
Bewtra Meenakshi, Kaiser Lisa M, TenHave Tom, Lewis James D, Inflammatory Bowel Diseases, 3/1/2013
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda
Denson Lee A, Long Millie D, McGovern Dermot P B, Kugathasan Subra, Wu Gary D, Young Vincent B, Pizarro Theresa T, de Zoeten Edwin F, Stappenbeck Thaddeus S, Plevy Sco..., Inflammatory Bowel Diseases, 3/1/2013
Quality indicators for inflammatory bowel disease: development of process and outcome measures
Melmed Gil Y, Siegel Corey Allan, Spiegel Brennan M, Allen John I, Cima Robert, Colombel Jean-Frederic, Dassopoulos Themistocles, Denson Lee A, Dudley-Brown Sharon, Ga..., Inflammatory Bowel Diseases, 3/1/2013
Update on Depression and Age-Related Macular Degeneration
Casten RC, Rovner BW, Current Opinion in Ophthalmology, 1/1/2013
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans
Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH,..., Inflamm Bowel Dis, 12/1/2012
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results
Long Millie D, Kappelman Michael D, Martin Christopher F, Lewis James D, Mayer Lloyd, Kinneer Patricia M, Sandler Robert S, Inflammatory Bowel Diseases, 11/1/2012
Genes Associated with Intestinal Permeability in Ulcerative Colitis: Changes in Expression Following Infliximab Therapy
Toedter G, Li K, Sague S, Ma K, Marano C, Macoritto M, Park J, Deehan R, Matthews A, Wu GD, Lewis JD, Arijs I, Rutgeerts P, Baribaud F, Inflammatory Bowel Diseases, 8/1/2012
Aetna Choice POS II BCBS Blue Card PPO BCBS California PPO CIGNA HMO CIGNA Open Access CIGNA PPO Excellus BCBS BluePPO GHI PPO
Great West PPO Health Net California Large Group PPO HIP of New York - Select PPO MagnaCare PPO Multiplan PHCS PPO Multiplan PPO United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: